Rai PK, Lalramnghinglova H (2011) Ethnomedicinal plants of India with special reference to an Indo-Burma hotspot region: an overview
All studies were blinded and placebo-controlled
Alternatively, other research has linked GLP-1 receptor agonists particularly semaglutide to an increased risk for suicidal ideation
in SUSTAIN-6, 1 mg of semaglutide lowered SBP more than the 0.5 mg dose [15]
Zepbound (tirzepatide) FDA-approved for chronic weight management in 2023, Zepbound is a once-weekly injection thats available in a 2.5mg, 5mg, 10mg, 12.5mg, and 15mg dosage
This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications